The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists

AIMS: This study aimed to clarify the renal influence of glucagon-like peptide 1 receptor agonists (GLP1Ras) with or without sodium-glucose co-transporter 2 inhibitors (SGLT2is) on Japanese patients with type 2 diabetes mellitus (T2DM). METHODS: We retrospectively extracted 547 patients with T2DM wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Kazuo, Toyoda, Masao, Hatori, Nobuo, Tsukamoto, Shunichiro, Kimura, Moritsugu, Sakai, Hiroyuki, Furuki, Takayuki, Chin, Keiichi, Kanaoka, Tomohiko, Aoyama, Togo, Umezono, Tomoya, Ito, Shun, Suzuki, Daisuke, Takeda, Hiroshi, Degawa, Hisakazu, Hishiki, Toshimasa, Shimura, Hidetoshi, Nakajima, Shinichi, Miyauchi, Masaaki, Yamamoto, Hareaki, Hatori, Yutaka, Hayashi, Masahiro, Sato, Kazuyoshi, Miyakawa, Masaaki, Terauchi, Yasuo, Tamura, Kouichi, Kanamori, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540913/
https://www.ncbi.nlm.nih.gov/pubmed/37779602
http://dx.doi.org/10.1097/XCE.0000000000000292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540913/
https://www.ncbi.nlm.nih.gov/pubmed/37779602
http://dx.doi.org/10.1097/XCE.0000000000000292

Ejemplares similares